User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Influenza vaccine efficacy trials: a simulation approach to understand failures from the past

  1. Dewé, Expert Review of Pharmacoeconomics & Outcomes Research, 6, 403 (2013)
  2. McElhaney Janet E, Beran Jiri, Devaster Jeanne-Marie, Esen Meral, Launay Odile, Leroux-Roels Geert, Ruiz-Palacios Guillermo M, van Essen Gerrit A, Caplanusi Adrian, Claeys Carine, Durand Christelle, Duval Xavier, El Idrissi Mohamed, Falsey Ann R, Feldman Gregory, Frey Sharon E, Galtier Florence, Hwang Shinn-Jang, Innis Bruce L, Kovac Martina, Kremsner Peter, McNeil Shelly, Nowakowski Andrzej, Richardus Jan Hendrik, Trofa Andrew, Oostvogels Lidia, AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial, 10.1016/s1473-3099(13)70046-x
  3. Gupta Vishal, Earl David J., Deem Michael W., Quantifying influenza vaccine efficacy and antigenic distance, 10.1016/j.vaccine.2006.01.010
  4. Bender Ralf, Augustin Thomas, Blettner Maria, Generating survival times to simulate Cox proportional hazards models, 10.1002/sim.2059
  5. Longini Ira M., Halloran M. Elizabeth, A Frailty Mixture Model for Estimating Vaccine Efficacy, 10.2307/2986152
  6. SMITH P G, RODRIGUES L C, FINE P E M, Assessment of the Protective Efficacy of Vaccines against Common Diseases Using Case-Control and Cohort Studies, 10.1093/ije/13.1.87
  7. Halloran, Design and Analysis of Vaccine Studies (2012)
  8. Chao Dennis L., Halloran M. Elizabeth, Obenchain Valerie J., Longini Ira M., FluTE, a Publicly Available Stochastic Influenza Epidemic Simulation Model, 10.1371/journal.pcbi.1000656
  9. Burman Carl-Fredrik, Hamrén Bengt, Olsson Per, Modelling and simulation to improve decision-making in clinical development : Modelling and simulation, 10.1002/pst.153
  10. Burman Carl-Fredrik, Wiklund Stig Johan, Modelling and simulation in the pharmaceutical industry-some reflections, 10.1002/pst.523
  11. Cox, Journal of the Royal Statistical Society. Series B (Methodological), 34, 187 (1972)
  12. Lofgren E., Fefferman N. H., Naumov Y. N., Gorski J., Naumova E. N., Influenza Seasonality: Underlying Causes and Modeling Theories, 10.1128/jvi.01680-06
  13. Burton Andrea, Altman Douglas G., Royston Patrick, Holder Roger L., The design of simulation studies in medical statistics, 10.1002/sim.2673
  14. Cooray Kahadawala, Generalization of the Weibull distribution: the odd Weibull family, 10.1191/1471082x06st116oa
  15. Reed William J., A flexible parametric survival model which allows a bathtub-shaped hazard rate function, 10.1080/02664763.2010.516388
  16. Tsai Rodrigo, Hotta Luiz Koodi, Polyhazard models with dependent causes, 10.1214/12-bjps185
  17. Demarqui Fabio N., Loschi Rosangela H., Colosimo Enrico A., Estimating the grid of time-points for the piecewise exponential model, 10.1007/s10985-008-9086-0
  18. Kim J.S., Proschan F., Piecewise exponential estimator of the survivor function, 10.1109/24.87112
  19. Flunet http://www.who.int/influenza/gisrs_aboratory/lflunet/en/
  20. Réseau sentinelles, INSERM/UPMC http://www.sentiweb.fr
  21. Kuehnert, Clinical Infectious Diseases, 8, 1094 (2003)
  22. Duchateau, The Frailty Model (2008)
  23. Mossong Joël, Hens Niel, Jit Mark, Beutels Philippe, Auranen Kari, Mikolajczyk Rafael, Massari Marco, Salmaso Stefania, Tomba Gianpaolo Scalia, Wallinga Jacco, Heijne Janneke, Sadkowska-Todys Malgorzata, Rosinska Magdalena, Edmunds W. John, Social Contacts and Mixing Patterns Relevant to the Spread of Infectious Diseases, 10.1371/journal.pmed.0050074
  24. Halloran M. E., Longini I. M., Struchiner C. J., Estimability and Interpretation of Vaccine Efficacy Using Frailty Mixing Models, 10.1093/oxfordjournals.aje.a008858
  25. Halloran M. Elizabeth, Struchiner Claudio J., Study Designs for Dependent Happenings : , 10.1097/00001648-199109000-00004
  26. McElhaney J. E., Xie D., Hager W. D., Barry M. B., Wang Y., Kleppinger A., Ewen C., Kane K. P., Bleackley R. C., T Cell Responses Are Better Correlates of Vaccine Protection in the Elderly, 10.4049/jimmunol.176.10.6333
  27. Pickles Andrew, Crouchley Robert, A comparison of frailty models for multivariate survival data, 10.1002/sim.4780141305
  28. Truscott J., Fraser C., Cauchemez S., Meeyai A., Hinsley W., Donnelly C. A., Ghani A., Ferguson N., Essential epidemiological mechanisms underpinning the transmission dynamics of seasonal influenza, 10.1098/rsif.2011.0309
  29. Centers for Disease Control and Prevention, MMWR Recomm Rep., 57, 1 (2008)
  30. Reed Carrie, Meltzer Martin I., Finelli Lyn, Fiore Anthony, Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine, 10.1016/j.vaccine.2011.12.098
  31. Hahn Gerald J., Meeker William Q., Statistical Intervals : A Guide for Practitioners, ISBN:9780470316771, 10.1002/9780470316771
  32. Agresti, The American Statistician, 2, 119 (1998)
  33. Benoit A Dewé W Legrand C Performances of regression models in estimating infectious diseases vaccine efficacy
  34. Glidden David V., Vittinghoff Eric, Modelling clustered survival data from multicentre clinical trials, 10.1002/sim.1599
  35. Ulrichs, Modern Infectious Disease Epidemiology, 279 (2010)
Bibliographic reference Benoit, Anne ; Legrand, Catherine ; Dewé, Walthère. Influenza vaccine efficacy trials: a simulation approach to understand failures from the past. In: Pharmaceutical Statistics : the journal of applied statistics in the pharmaceutical industry, Vol. 14, no.4, p. 294-301 (2015)
Permanent URL http://hdl.handle.net/2078.1/183237